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Abstract: In this review, we evaluated health care problems, which were not common before pandemic outbreak but have been common
issues after its appereance and approaches to control pandemic considering its influences on people. We revised current health care
developing approaches under the light of experience obtained throughout the pandemic so far. The aim is to be prepared in advance
for possible upcoming pandemics. As in Covid 19 pandemics, such long lasting and widely affecting situations, durability is also very
important together with flexibility and quickness. To provide durability, we need global policies taking the health to its center as well as
health system policies.
Key words: Covid-19, health system, emergency, crisis, vulnerability, durability

1. Introduction
Covid-19, the new strain of human coronavirus emerged
in Wuhan city, China, was officially identified as a
pandemic by the World Health Organisation (WHO) upon
receiving breakout reports from nearly every continent
[1,2]. Throughout history, these kinds of pandemics not
only affected infected individuals but also entire societies
in numerous ways: economic, social, psychological, and
physical [3]. Despite warnings that had been around for
tens of years, many countries were unprepared for the
Covid-19 pandemic. While some managed to effectively
control it, others failed [4]. Its other effects on health and
social life will probably only be understood in the long
term [4]. By end of July 2021, approximately 4.1 million
people lost their lives due to Covid-19.
2. Isolation effects
One of the most frequently used and historic methods
for controlling pandemics is imposing quarantines.
Depending on the type of the disease, there could be slight
differences in the implementation of a quarantine; it is a
dynamic process that requires regular updates according
to changing conditions and selected pathology method.
On the one hand, isolating people during these hard times
provides many benefits, while it can cause some undesired
personal and social outcomes. Due to Covid-19’s mode of

transmission, terms such as quarantine, isolation, social
distance, etc. have been a part of our daily lives. In the
article titled “A Desperate Plea”, Richard Horton mentions
how an important aspect of the pandemics has been
underestimated [5]. This text points out that while focusing
on macroscopic aspects of the pandemics, microscopic
effects should not be disregarded as these tend to
exacerbate hopelessness, fear, and stress among the society
[5]. This is very important as the paramedical side effects of
the pandemics should not be forgotten. Many studies have
shown that isolation negatively affects the patient’s care
and satisfaction. There are two overarching reasons behind
these negative effects, one is patient-related and the other is
healthcare worker-related [6, 7]. Abad and his colleagues,
in an extensive review that they prepared with data
spanning a period of 43 years, showed that isolated patients
were more negatively affected in terms of psychological
wellness, satisfaction, and feeling safe [6]. Furthermore,
studies that evaluate pandemics, including Covid-19, and
asses the psychological wellbeing of the health workers,
report that health workers tend to minimize contact with
their patients. It has been hypothesized that this stems
from a lack of accurate information among health workers
about the topic and the fear of contracting the disease
from patients and transmitting it to their families [6, 8].
Therefore, disruptions to the routine healthcare provisions
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and a decrease in overall healthcare quality are expected.
To minimize such negative outcomes, there are some
suggestions and strategies [9]. New digital technologies
can support treatment and care processes in both hospitals
and the region [10]. The regular control of patients’ vital
parameters via wearable technologies and smartphones
could guarantee better management of health services [9].
Additionally, technological advancement can allow remote
control of some medical devices, thereby minimizing
contact between medical staff and infected patients [9, 11].
3. Overuse of antibiotics
Historically, one of the reasons why pandemics lead to
devastating outcomes has been the inability to find a
treatment during the acute phase of the disease. Currently,
there is no effective treatment against Covid-19 pneumonia
caused by SARS-CoV-21. The absence of an effective
treatment for the disease can lead to the inappropriate use of
antibiotics [12, 13]. It is an irrefutable truth that antibiotics
are useless in viral pneumonia. In the treatment guidelines
prepared by our ministry of health, antibiotic treatment
is only suggested when there is a suspicion of bacterial
pneumonia1. The rising pressure on health systems due to
the pandemic, difficulty in Covid 19 diagnosis, and doctors’
tendencies to not take risks decreased the adherence to
the guidelines. Globally, the situation was no different.
While early deescalation attempts are recommended, the
high workload in emergency rooms and microbiology
laboratories, the absence of an evidence-based treatment
of Covid-19, the stress factor on doctors, and the antibiotic
presence in the WHO guidelines for the disease caused a
rise in antibiotic use rates2 [12, 13]. The use of antibiotics
in SARS-CoV-2 patients is significantly higher than
bacterial coinfection and secondary infection incidences.
According to metaanalyses, 7%–8% of the patients who
are diagnosed with Covid-19 have developed bacterial
or fungal infections [14]. In the patients in intensive care
units (ICU), this rate is higher (8%–14%). Only 3.5% of
the patients had co-infections while 14.3% had secondary
infections [15, 16]. Although bacterial infection notification
rates were low, antibiotic use in Covid-19 patients was quite
high, and 71.9% of these patients took antibiotics; 74% of
the prescribed antibiotics were fluroquinolones and thirdgeneration cephalosporins [15]. For the appropriate use of
antibiotics in Covid-19 patients, it is important to classify
patients as being either ventilated-critical, hospitalized but
not ventilated, or outpatient. Thus, proper criteria for each
group will open a door to smarter antibiotic use [17]. In
a recent study, there were low co-infection incidences in

critical patients, but the infections tended to develop after
hospitalizations [18]. On the other hand, although detailed
data is missing, a first look at the data showed us outpatient
antibiotic use may be diminished in some places either due
to lockdown effects on other diseases’ transmissions or the
limitations on healthcare services or a combination of both
[19]. However, antibiotic use in many Covid-19 patients
globally increased in comparison to the pre-pandemic
period [12, 20, 21]. There is a need for more studies to
assess the possible negative effects of using disseminated
antibiotics. The expected result is that antibiotic resistance
increases as an outcome of increased antibiotic use.
Covid-19 pandemic’s effect on antimicrobial drug resistance
is still not fully understood [19, 22–26]. Because the mode of
SARS-CoV-2 transmission requires more attention on hand
hygiene and use of personal protective equipment (PPE),
these could have positive effects on antimicrobial drug
resistance [27, 28]. On the other hand, an uncontrolled rise
in the number of patients and difficulty in reaching PPE can
motivate multidrug resistant bacteria to manifest [27–29].
As the pandemic grew, the staff members and resources used
in monitoring antimicrobial drug resistance were directed
towards diagnosis and the follow up of Covid-19 patients.
Including anti-microbial drug follow ups, all of the nonCovid-19 studies were interrupted or dropped. As countries
applied international travel restrictions, the info sharing and
activities to build up international networks were disrupted
[17]. To maintain antimicrobial drug resistance research,
they should be financially supported and efforts to sponsor
these activities should be prioritized. It is important to
ensure current sample collecting and studies on diagnosis
tools are being developed in order to support activities
regarding antimicrobial drug resistance [17]. It is necessary
to develop standardized protocols for Covid-19 related coinfections and secondary infections under the mentorship
of WHO researchers. If implemented correctly, data
flow between research centers would be guaranteed [30].
Resistance follow ups in both Covid-19 and non-Covid-19
patients should continue [31–34]. Epidemiological data
from colonized patients, high risk patients, or infected
patients should be collected. In high risk areas (such as
ICUs and hematology departments) and especially when
cohorting is used in Covid-19 patients, active surveillance
for colonization in high risk patients should continue.
4. Problems in chronic disease follow-ups
4.1. Patients with cardiovascular diseases
As the pandemic grew dramatically, Covid-19 patient load
led to capacity problems in emergency rooms and ICUs;

TCSBHSGM. COVID-19 (SARSCOV2 Enfeksiyonu) Rehberi (Bilim Kurulu Çalışması) 2020 [Available from: https://covid19bilgi.saglik.gov.tr/depo/
rehberler/COVID-19_Rehberi.pdf?type=file.
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it also affected the availability of PPE and led to problems
in medical staff sufficiency. Because of this, medical
institutions limited or postponed elective operations and
lowered the patient care. On the other hand, management
of the patient groups who required urgent or regular
care was deemed a medical emergency that had to be
orchestrated amongst the challenges of the Covid-19
pandemic. Cardiovascular diseases are an example of
these kind of diseases. One third of worldwide deaths is
caused by cardiovascular diseases. The management of the
acute myocardial infarction is important in this Covid era.
Although there is a link between cardiovascular diseases
and Covid-19, most of the patients who need cardiovascular
care may not be infected with this virus [35]. Clearly, it is
a hard task to give recommendations for acute myocardial
infarction patients during a pandemic. Considering the risk
of Covid-19’s asymptomatic spread, some cardiovascular
signs of Covid-19 might be confused with various coronary
emergencies, and this makes management of these patients
even harder [35]. In some regions Covid-19 spread among
the society is high and sensitivity of the test is problematic
[31, 35–37]. In addition, some positive tested patients
can be asymptomatic although the findings are present
in computerized tomography. It must be known that
asymptomatic spread rate is high [36, 37]. For this reason,
without taking the Covid situation into account, it is
important to properly assess patients who need invasive
intervention, making sure medical staff who could be
exposed to the virus are safe and that contamination
risk during cardiac catheterization is minimized. In the
guidelines prepared by Mahmoud and his colleagues,
there is a systematic approach for patients who experience
acute myocardial infections during the Covid-19 era [35].
According to these guidelines, the first goal should be
taking measures to minimize Covid-19 exposure among
the society, thus guaranteeing that patients who show up
with acute ischemic cardiac disease symptoms continue
to access medical services without interruption [35]. In
indicated patients, percutaneous coronary intervention
and fibrinolytic use should not be avoided. Patients who
undergo intervention must be wearing masks and PPE in
order not to endanger healthcare workers [35]. In some
conducted studies, it was found that there are prolongations
between acute cardiac symptom onset times and hospital
arrival times [38]. This can lead us to think that, during the
pandemic, there could be some difficulties to reach medical
care. Since everyone primarily focuses on respiratory
symptoms during pandemic, some misdiagnoses could
occur, and the quality of medical care could suffer [15].
It is important to develop effective strategies for cardiac
emergencies and simultaneously make sure both of these
important emergency situations, Covid-19 and acute
cardiac problems, are being properly managed.
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4.2. Patients with chronic kidney disease
Chronic kidney disease is a public health issue that
affects 850 million people worldwide [39]. Chronic
kidney disease patients are generally elderly people with
many comorbidities [40]. Some of these may require
immunosuppressive treatment. Patients who need
regular dialysis are also at high risk of contamination
during the pandemic [41]. Taking all of these factors into
consideration, we can say that chronic kidney disease
patients are more prone to get infected with Covid-19
in comparison to the general population [40, 41].
Furthermore, contracting Covid-19 can result in sudden
kidney function test disorders and even death [40]. In
order to mitigate the pandemic’s destructive effects,
experts in this field gathered and published suggestions
[42, 43]. These suggestions can be grouped into three
categories: ones for health care providers, ones for chronic
kidney disease patients, and ones for patients who take
dialysis and dialysis centers [42]. Healthcare providers
should mainly be giving attention to ensuring that the staff
who will be involved in these patients’ treatments and care
are wearing masks and other PPE. In addition, healthcare
providers should avoid crowded meetings and activities.
On the other hand, the staff working in healthcare
institutions should be able to follow up on their or their
patients’ symptoms and notify the responsible people
when necessary [41, 44, 45]. Chronic kidney disease
patients should avoid close interactions with others,
and treatments prepared for these individuals should be
under close supervision of their doctors. Also, as long
as it is possible, visits to hospitals should be minimized,
and online platforms should be promoted [41, 44, 45].
In dialysis units, traditional measures should be taken;
Covid-19 suspected patients should have an isolated place
separate from other patients. Also, dialysis should be as
late as possible during the day for those who are infected
with Covid 19. It is important that all the patients wear
masks during the dialysis as well [41, 44, 45]. Everyone
must follow the rules and medical protocols closely and
completely in order to ensure that these sensitive groups of
patients are minimally affected during this Covid-19 era.
4.3. Patients with malignancy
Another group of patients who require special treatment,
follow ups, and healthcare are patients with malignancies.
This group of patients are susceptible to Covid-19’s effects,
and it is essential for these patients to acquire health
services under carefully planned measures. Nevertheless,
the pandemic pushed many oncologists to change their
work routines. This negatively affected patients follow
ups and care as well as numerous cancer studies [46]. The
dependable health protecting measures taken among the
public in order to limit the virus’s spread has caused a
slowdown in many institutions, including cancer research
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laboratories [46, 47]. Scientific experimental research
requires sustained work, and it necessary in order to
provide the best care to cancer patients. Many centers tried
to change their programs without interrupting the studies
and adapted to the new conditions [46]. On the other hand,
some cancer research laboratories directed their efforts (in
antineoplastic agents) towards researching therapeutic
options for Covid-19 infections [46, 48]. The following
are some points oncologists underline in their cancer
research: 1) not leaving behind the patients whose survival
and prognosis are dependent on a research treatment, 2)
minimizing unnecessary exposure, and 3) reducing the
pandemic’s exposure curve and increasing patients’ and
research teams’ motivations [49]. As pandemic durations
became prolonged, the disease progression risk in these
patients left the Covid-19 infection risk from hospitals
behind [50]. Due to this reason, experts in this field
worked to prepare the best protocols in order to provide a
balance between managing these sensitive patient groups
and their protection from the virus. As the pandemic
continued, different oncology organizations kept
publishing suggestions and various guidelines regarding
the management of these sensitive patient groups [51].
However, in spite of these efforts, it is hard to suggest
optimal healthcare suggestions for these patients. Many
guidelines emphasize that the approach to cancer patients
should be dynamic and differ from patient to patient,
hospital resources, and doctors’ personal experiences [52,
53]. Oncologists should keep in mind that, if the Covid-19
pandemic escalates, the risk of not having high-level
medical care for cancer patients will be greater than the
SARS-CoV-2 infection risk for those patients [46, 54]. The
primary strategy was stopping or postponing palliative care
for poor prognosis expected patients and giving priority to
emergencies for aggressive diseases [55]. Also, protecting
the medical staff was important for patient safety. Kimmig
and his colleagues emphasized that choosing laparoscopic
procedures in oncological surgery is important to protect
medical staff by minimizing their exposure to aerosols
[56]. Carbon dioxide gas management and appropriate
filter use was brought into attention [57]. In some centers
screening facilities and oncology services were re-designed
to provide safer accommodations for patients [58]. Most
of the doctors preferred non-surgical invasive procedures
in cases that did not necessarily require surgery, as fecal
and oral transmission of the virus had not been completely
ruled out. Also, many surgeons encouraged the avoidance
of endoscopic procedures [59]. For medical treatment,
it was generally recommended to decrease adjuvant
chemotherapy frequency and density [60]. Some clinics
formulated algorithms according to the specific situation
in their respective countries. In Italy, where the destructive
effects of the pandemic have clearly been seen, a hospital

suggested an algorithm for uro-oncological operations
where they classified the patients. Cases like muscle invasive
bladder cancers or locally-advanced prostate cancers were
not to be delayed while some cases were half undelayable
and some others are delayable. Another category was the
group of diseases in which other nonsurgical treatments
could be an alternative to surgery [53].
5. Mental health
Emergency situations that concern public health, such
as pandemics and wars, also closely affect social security,
health, and prosperity. These can have influences on mental
health as well. Studies dealing with emergency cases’
effect on mental health have proposed that emotional
effects can be present in every layer of society [61]. The
case of Covid-19 is no different. Some groups are more
vulnerable to the pandemic’s psychosocial effects. One of
the most important groups here are healthcare workers.
Healthcare workers generally work in the front lines in
such emergency cases. Mental wellbeing among healthcare
workers would also have globally positive effects on social
recovery along with controlling the effects of the pandemic
[62]. An increasing number of cases, absence of efficient
drugs and treatment protocols, inadequate amounts of
PPE, misinformation in media, increasing numbers of
Covid-19 related deaths among healthcare workers, and
not having sufficient psychosocial support are some of the
reasons behind the increasing psychological load among
healthcare workers [63, 64]. Medical staff did not know
much about Covid-19 since it began suddenly and spread
quickly. They also were not mentally prepared for this big
disaster. This caused psychological trauma at different
levels [65]. Depression, anxiety disorders, and insomnia
are some of the psychopathological problems among
healthcare workers [61]. In the conducted studies, it has
been shown that, during pandemics, negative psychological
reactions are becoming more prevalent among healthcare
workers [66, 67]. Studies showed that healthcare workers
were in fear of transmitting the disease to people they are
close to, and they are felt desperate about the pandemic’s
progress and often thought of leaving their jobs [66, 67].
Besides these factors, they were also experiencing high
levels of stress, signs of anxiety, and depression [68]. Posttraumatic stress disorder is a condition that more likely
occurs after natural disasters, technologic accidents and
attacks, and mass-destruction attacks. It is characterized
by mental imbalance following psychological trauma
[61]. Long lasting disasters are more often linked to posttraumatic stress disorders in comparison to short lasting
disasters. So, it is possible to say that pandemics cause
qualitatively and quantitatively more serious effects on
healthcare workers when compared to short lasting issues
[69, 70]. Findings that post-traumatic stress disorder
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rates are higher after the Covid-19 and SARS pandemics
actually showing healthcare workers are sensing those
as disaster [71–74]. The study regarding post-traumatic
stress disorders and their affiliated insomnia problems,
conducted by Bulut and his colleagues, had some important
discoveries. This study was also meaningful since it
was conducted in the Van province where the very first
suspected cases were seen and the first pandemic hospital
was designed. According to study, posttraumatic stress
disorder symptoms were seen in high rates in all healthcare
workers [63]. These symptoms were more frequently
found in women. According to the classification based
on jobs, nurses, especially those who are married, were
affected the most. In other related studies, similar results
were obtained. It was noted that nurses are in more contact
with patients during the day, they are mostly women, they
do not know about the disease as much as doctors, and
they were more likely to internalize the problems they
faced and present more psychological symptoms [64,
65, 71, 74–77]. It was also demonstrated that married
healthcare workers worried not only about themselves but
also their families and children [63, 72]. These kinds of
studies are important to assess which group of healthcare
workers are being affected more. Among the healthcare
workers, focus should be on the groups who carry more
psychosocial risks, and these groups should be prioritized
in psychoeducation, psychological support, and screening
for mental problems. In this process, a mobile application
called “RUHSAD” was created by the Ministry of Health
of the Republic of Turkey in order to protect and support
the mental health of healthcare professionals and their
children. With this application, healthcare professionals
and their children were allowed to make video calls with
specialist psychiatrists. In these video calls, priority was
given to those who were in quarantine due to Covid-19
whose test results were positive, whose relatives were
permitted in the ICUs, and who were assigned to the
Covid-19 units3. The measures that are being taken
during a pandemic should be multilateral. Besides this,
protecting these healthcare workers may be the most
important measure that could be taken towards Covid-19
and its effects on public health. Fighting this pandemic
with mentally powerful healthcare workers is an essential
component to winning this fight. Interventions to prevent
mental problems and develop strong mental health among

the healthcare workers fighting Covid-19 in front lines
should be applied in early period, and risk groups should
be strongly supported.
6. Taking social aspects of the pandemics into account
and making efforts to minimize harm to people during
global health crises
A comprehensive approach by those in authority would
help overcome these difficult times. Coordination and
collaboration among the authorities will lead to strong and
consistent responses to such a crisis. This, at the end, will
produce benefits to people struggling with the proposed
process. In this regard, the multilateral approach to health
topics that started in Turkey in 2011 has been an important
step. It can be a solid foundation as Turkey properly takes
care of its people during pandemic and shows efforts to
overcome the pandemic. During the Covid-19 pandemic,
it is important to be prepared in health and health system
aspects as well as for the social side of the problem. For
this purpose, a project, “COVID-19 ve Toplum: Salgının
Sosyal, Beşeri ve Ekonomik etkileri, Sorunlar ve Çözümler”
(COVID-19 and Society: Pandemic’s Social, Sociological
and Economic effects, Problems and Solutions) has
presented some results. According to the study, Covid-19
fear, obsessive compulsive symptoms, health worries,
negative feelings, and sleep quality have played important
roles in the pandemic in relation to citizens’ psychological
statuses. At this point, cognitive-behavioral approaches
may be beneficial for society while measures to assist
sociological mental health are being taken4. It is also
thought that online or mobile phone-based psychological
education and interventions might be an alternative to
support people. In our country, especially due to mental
problems, people do not regularly seek help in psychiatry
departments in hospitals. Mobile phones and online tools
could be suitable alternatives to help to cover the need. In
this context, mobile-based self-help intervention services
and providing free access to all would be a good method
to combat the problem. It is suggested that, while new
ideas are arising, these methods should be amplified by
using technology and modern solutions5. In Turkey, a
study with 3004 participants with ages ranging from 18
to 75 in 76 different cities has been carried out to stratify
risk groups by evaluating participants’ anxiety levels,
depression, somatization, hostility signs, and demographic

https://ohsad.org/saglik-bakanligi-saglik-hizmetleri-genel-mudurlugu-tarafindan-ruhsad-uygulamasi-hakkinda-duyuru-yayinlandi/. Published 2020,
[accessed June 12, 2021]
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Yaklaşımı. https://www.tubitak.gov.tr/sites/default/files/Covid19veToplum/ozet-ozgecmis/23SUBAT/FEZAGURSEYSALONU/10.00-11.30/
IlhanYALCIN_Ozet.pdf. Published 2021, [accessed June 12, 2021]
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Etkileri, Bulgular, Sonuçlar ve Öneriler. https://tubitak.gov.tr/sites/default/files/20689/covid_19_ve_toplum_salginin_sosyal_beseri_ve_ekonomik_
etkileri_sorunlar_ve_cozumler.pdf. Published 2021, [accessed June 12, 2021]
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parameters. This study reveals that women, single
individuals, people below 30 years old, people with lower
income and education levels, people who are diagnosed
with at least one psychiatric disorder, and people who have
close relatives affected with Covid-19 have developed more
psychological symptoms and signs. It is assessed that mass
communication tools and online platforms should be used
more effectively and should be primarily considered while
intervention plans are being developed for these target
groups6. In another study, the intrepidity experiences
of people who contracted Covid-19 and recovered were
mainly classified into four groups: 1-Preventive factors,
2-Risk factors, 3-Positive outcomes, 4-Feelings. The main
preventive factor was social support, and this clearly
suggests that more efforts need to be shown in order to
improve relations with friends, families, and relatives. This
may be through remote communication using mobile
phones, laptops, and any other current technological tools.
Inner preventive factors, such as hope and optimism,
can help and accelerate medical treatment success and
aid in producing positive outcomes. Risk factors include
social isolation, interruption in education, and economic
difficulties. Positive outcomes include improvement with
family relationships, discovering new possibilities for
selfadvancement, and having a new viewpoint towards
life7. In another study that dealt with Covid-19’s effects
on children and adolescents, as well as their mothers in
terms of their cognitive- psychosocial improvement and
academic life, it was documented how difficulties that
children face through distant education also negatively
affect their mothers. Mothers were found to have more
depression and higher stress levels in comparison to preCovid times8.
7. Overcoming the pandemic
Vaccine development has never progressed this quickly
and successfully. Conventional vaccine development
time used to be approximately 10–15 years; during the
Covid-19 pandemic, this duration has been decreased
to a remarkable 12–18 months. In order to make this
achievement, the time required for each step of the vaccine
development process has been shortened. At the same
time, parallel work has been implemented, and approval
times for developed vaccines has been shortened. Some

countries contributed financially to this quick vaccine
process. We also have to note that previous work, which
focused on MERS-CoV and some cancer vaccines, has
helped in the accelerated development of the Covid-19
vaccine. The accumulated information was channeled
in the context of this new pandemic. Taking all of these
factors into account, these vaccine studies provided the
expected result in record time. It is important to note,
again, that applying emergency approval procedures for
vaccines also aided these vaccines to be immediately put
in use. Accelerating factors such as these should always be
considered with any given potential global health problem;
however, it is still essential to properly clarify them and
their boundaries. Easy access to data and new information,
mutual budgets for further researches, optimization of
early approval processes, determining the sustainable
rules for copyrights issues, and optimization of the global
approach towards personal and political interests, as well
as everyone’s right to access health services fairly, are
crucial.
8. Increasing access to vaccines and patent rights issues
Patents serve as the recognized copyright of any product
or service that has been implemented, providing legal
protection for inventors. It has a long history going back
to the 1400s; since then, this process has been revised and
developed many times. Practically, a patent offers three
important benefits:
1-It serves as a motivator for new research and future
inventions;
2-It provides merriment, prestige, and economic
advantages to inventors—so, new research and projects
are always underway;
3-By protecting new technologies, it allows patent
owners to invest in different countries, thereby spreading
the technology or idea [78].
In the context of vaccines, a patent may include vaccine
formulations, any other substances added to formula,
automatic injectors needed for its application, nasal
application tools, capsule formulations, and many other
related things. During this process, conditions for quality
and control issues and transportation requirements may
occur. In addition, trademark rights and secrets regarding
the process would be protected; know-how topics are
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also included here. One of the most important functions
of patent rights in vaccine production is motivating
sponsorship in research and development investments. If
no financial support is provided, development in this field
cannot be expected. A quality control system is another
critical step here, especially in the sense of effectiveness
and quality. Public acceptance is a key point in vaccination
program success. This is valid for any vaccine9. To end
the Covid-19 pandemic, it is essential to deliver effective
vaccines to all countries and all social groups within them.
There are some barriers for broad access to vaccines,
such as vaccine development, production, distribution,
implementation, and acceptance by people as well as
follow ups during the postvaccination period. All of these
steps must build off one another smoothly to determine
that the vaccination program is successful. Unless all
these steps are successfully carried out, it is useless to
sacrifice patent rights and expecting all the obstacles to
spreading the vaccination program to disappear. Together
with sacrificing patent rights, convenient infrastructure
for production, and know-how transference, proper
quality control processes should be completed. Vaccine
accessibility can be improved though a tiered pricing
system that is already in use for many vaccines. For the
potential new pandemics that can spread widely and
require new drugs/vaccines, vaccine development and
legal studies to build a strong base for those efforts should
continue. New regulations and ideas will better help
vaccine accessibility worldwide and motivate people who
are dealing with this important subject. Although the last
pandemic deeply affected almost every country (i.e. the
Ebola virus epidemic in 2014) countries with poor health
infrastructures are more heavily impacted. To combat
infectious diseases and their effects such as the one we
are fighting now, it is important to fortify health systems
and recruit human sources in the current medical system.
Human resources in the medical field should be planned
to effectively preserve both quality and quantity. While
clarifying missions for each branch, it is also necessary
to retain vocational training10. In case of extraordinary
situations, such as pandemics, we may need to re-organize
the healthcare system’s human resources without totally
neglecting their primary fields of responsibility.

9. Being ready
There are pandemic plans prepared and regularly updated
by WHO as well as by various governments. If these
plans are regularly being regulated and updated, it would
allow the governments to take better action in a timely
manner and increase their capacity to fight pandemics.
This has been tested during Covid-19 too. Turkey had
updated its influenza pandemic plan in 2019; taking
some similarities between Covid-19 and influenza into
account, this allowed Turkey to react properly and quickly
to the Covid-19 pandemic11. The Covid-19 pandemic has
caused an unforeseen and complex situation in global
health institutions and countries. An effective response
to the pandemic required alternative approaches for the
institutions who provide health services. The Covid-19
pandemic is an example of how a small and surprisingly
isolated incident somewhere in the globe can actually have
a huge influence on how medical practices are performed.
This surprising side could be summarized in three
titles: complexity of its root, the rate or spread, and the
unpredictability of the pandemic`s effect. Health service
providers had common shared problems as well as unique
ones. Some of these were the need for PPE, patient bed
capacity, intensive care unit bed capacity, ventilator needs,
and the need for enough medical professionals. To solve
these problems, institutions and countries reorganized
themselves quickly. This reorganization process included
reforming treatment and patient care models, keeping the
medical professionals’ motivation and abilities high, and
lowering their levels of anxiety. Another issue has been
that of financial sustainability of hospitals and maintaining
services for non-Covid-19 patients. Additionally, in
the future, if a disaster like a terrorist attack or another
pandemic occur, health institutions will have to arrange
themselves according to the new state. During the Covid-19
pandemic, international organizations as well as national
and regional institutions have gained the flexibility to
immediately adapt to any new and unforeseen situations.
This could be seen as an opportunity in this context12
[79,80]. When the very first cases were announced in
China, while not many cases were seen in Turkey, a
national advisory committee was formed. This committee
had valuable insight and quickly suggested guidelines for
patient care. These guidelines have been used in hospitals,
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Table. Main guides for health care professionals during COVID-19.
Main guides

Content

Working guide and infection control measures

In health institutes, how health care professional work and what kinds of
measures should be taken are all explained in this guide.

COVID-19 (SARS-CoV-2 INFECTION): General
information, epidemiology and diagnosis

In this guide, the definition, epidemiology and case process (case detection,
case tracking and case management) are explained.

Adult patient treatment

This guide explains the process of adult patient treatment.

Child patient management and treatment

It includes child patient management process and treatment process during
COVID-19.

Antitoxin, antiinflammatory treatments,
coagulopathy management

It includes main recommendations for the treatment of hyperinflammatory and
the management of coagulopathy during COVID-19.

Contact monitoring, outbreak management,
monitoring patient at home and filiation

It explains the process of contact monitoring excluding health care
professionals. This guide also includes pandemic management, filiation process,
and monitoring patient at home.

Infection control and isolation

It includes the process of infection control and isolation.

Morgue and burial services

It includes process of morgue and burial services through main measures
during COVID-19.

(*) Adapted from reference 81.

to inform the public and for the medical personnel [81].
Here are some of those guidelines that have been used to
educate medical professionals, as seen in Table.
10. Resilience to other potential pandemics
In most of the international organizations and developed
countries, regular practices for catastrophic situations are
being made. It is not a single decision, rather these must
be made on a regular basis in order to keep the necessary
systems alert and prepared for such crises. These practices
are implemented through a viable scenario and not based
on unreal fictions. Scenarios are based on real problems that
are not present at the moment13. Some different disasters,
such as pandemics, may force us to make preparations with
limited timeframes. However, most of the time crisis plans
are still useful, at least in early phases of pandemics. It
gives us a chance for re-organizing ourselves and our long
term efforts. Considering this, national crisis plans should
be worked on in advance. Since the Almaty declaration in
1978, health and multisectoral approach have been going
forward together. Terms such as Sustainable Development
Goals (SDG) and One-Health concept and Health in All
Policies (HiAP) are building a base for a multisectoral

approach. Social determinants have come into prominence
for health alongside these processes14. For health systems
to manage crises and be successful, they should be properly
orchestrated. To maintain the durability of the health
system, we have to place health and related issues in the
center of global policies, as seen in Figure.
As countries’ practices of multisectoral approaches
develop, we can expect health crises such as pandemics that
have disastrous effects to be easier to overcome. As HiAP
concept and leave-no-one-behind approach are embraced
more readily, we could have a better chance in our fight
with the pandemic. The Covid-19 pandemic showed us
that it is useless to group health services into preventive
and treatment services or infectious diseases and
noninfectious diseases [82]. Organizations giving priority
to maintaining global health security and universal health
coverage, together in balance without needing external
funds, are more likely to be successful in the Covid-19
era in comparison to fragmented health institutions [83].
Placing the health topics in the center of all policies helps
in building a new health system concept that will help us
to have better results in improvement efforts. This will also
help minimize future pandemics’ destructive results.
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Patient management

•Evidence-based patient
care

Health system
resilience/agility

•Hospitals
•Drugs and vaccine
•Personal
•Finance

Governance

•Health in all politics
•Equity for health
•Don't leave no one
behind

Figure. Durable and ready for crisis in health systems.

11. Conclusion
The Covid-19 pandemic time has been a test for national
and global health institutions’ capacities to fight such
crises. Having observed failures alongside partly- and
fully-successful examples, we now have ideas for possible
upcoming crises. At the same time, for complete success,
it has been clear that no one should be left behind; this
approach is mandatory. Although there are many plans,
guidelines, and maneuvers prepared by national and
global organizations, in practice, things might be different
in the moment of crisis. For these to be practiced easily,
information must be flexible and internalized by all acting

parties and their supporters, because no crisis will be the
same as a previous one. Resilience, alongside flexibility
and quickness, is critical in long lasting and large scale
disasters like Covid-19. In order to achieve this level of
resilience, we need global policies that critically consider
physical and mental health practices as well as health
system policies.
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